This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.

JMP Securities Hematology and Oncology Summit
Fireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET
Location: Virtual

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.43
-3.60 (-1.62%)
AAPL  258.63
-4.14 (-1.58%)
AMD  229.02
-9.01 (-3.79%)
BAC  50.84
-0.68 (-1.32%)
GOOG  253.97
+2.63 (1.05%)
META  730.08
-3.19 (-0.44%)
MSFT  522.08
+4.42 (0.85%)
NVDA  179.25
-1.91 (-1.05%)
ORCL  272.04
-3.11 (-1.13%)
TSLA  433.32
-9.28 (-2.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.